AVITA Medical, Inc. (AVH.AX)
AUD 2.87
(-3.69%)
AUD 2.87
(-3.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -27.5 Million USD | 20.3% |
| 2021 | -34.51 Million USD | -30.04% |
| 2020 | -26.54 Million USD | 37.81% |
| 2019 | -42.67 Million USD | -17.37% |
| 2018 | -36.36 Million AUD | -176.87% |
| 2017 | -13.13 Million AUD | -34.27% |
| 2016 | -9.78 Million AUD | 5.01% |
| 2015 | -10.29 Million AUD | -67.38% |
| 2014 | -6.15 Million AUD | 2.5% |
| 2013 | -6.3 Million AUD | 15.91% |
| 2012 | -7.5 Million AUD | -28.74% |
| 2011 | -5.82 Million AUD | -33.06% |
| 2010 | -4.37 Million AUD | -68.78% |
| 2009 | -2.59 Million AUD | 36.09% |
| 2008 | -4.06 Million AUD | 7.04% |
| 2007 | -4.36 Million AUD | 3.86% |
| 2006 | -4.54 Million AUD | 50.58% |
| 2005 | -9.19 Million AUD | 0.0% |
| 2003 | -4.97 Million AUD | -207.56% |
| 2002 | -1.61 Million AUD | -25.28% |
| 2001 | -1.29 Million AUD | -359.04% |
| 2000 | 498.37 Thousand AUD | 311.44% |
| 1999 | -235.7 Thousand AUD | -115.65% |
| 1998 | 1.5 Million AUD | 1650.39% |
| 1997 | -97.15 Thousand AUD | 30.01% |
| 1996 | -138.81 Thousand AUD | -9.69% |
| 1995 | -126.54 Thousand AUD | 54.56% |
| 1994 | -278.47 Thousand AUD | -33.93% |
| 1993 | -207.92 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -11.16 Million USD | -12.65% |
| 2023 Q3 | -9.3 Million USD | 16.65% |
| 2023 Q1 | -9.91 Million USD | -67.76% |
| 2022 Q2 | -6.36 Million USD | 32.94% |
| 2022 Q4 | -5.9 Million USD | -2.78% |
| 2022 Q3 | -5.74 Million USD | 9.65% |
| 2022 Q1 | -9.48 Million USD | -11.95% |
| 2022 FY | -27.5 Million USD | 20.3% |
| 2021 FY | -34.51 Million USD | -30.04% |
| 2021 Q1 | -5.99 Million USD | -6.39% |
| 2021 Q2 | -4.7 Million USD | 21.48% |
| 2021 Q3 | -5.94 Million USD | -26.47% |
| 2021 Q4 | -8.47 Million USD | -42.44% |
| 2020 Q2 | -13.02 Million USD | 15.47% |
| 2020 FY | -26.54 Million USD | 37.81% |
| 2020 Q1 | -15.4 Million USD | -45.45% |
| 2020 Q3 | -10.21 Million USD | 21.57% |
| 2020 Q4 | -5.63 Million USD | 44.87% |
| 2019 Q1 | -10.14 Million USD | -29.48% |
| 2019 Q2 | -10.25 Million USD | -1.14% |
| 2019 Q4 | -10.59 Million USD | -189.56% |
| 2019 Q3 | -3.65 Million USD | 64.34% |
| 2019 FY | -42.67 Million USD | -17.37% |
| 2018 Q4 | -7.83 Million USD | 0.0% |
| 2018 FY | -36.36 Million AUD | -176.87% |
| 2018 Q3 | -7.83 Million USD | -28.47% |
| 2018 Q2 | -6.09 Million USD | -14.28% |
| 2018 Q1 | -5.33 Million USD | -46.7% |
| 2017 Q1 | -4.01 Million USD | -72.88% |
| 2017 Q4 | -3.63 Million USD | 0.0% |
| 2017 FY | -13.13 Million AUD | -34.27% |
| 2017 Q3 | -3.63 Million USD | 9.37% |
| 2017 Q2 | -4.01 Million USD | 0.0% |
| 2016 Q4 | -2.32 Million USD | 0.0% |
| 2016 FY | -9.78 Million AUD | 5.01% |
| 2016 Q2 | -3.05 Million USD | 0.0% |
| 2016 Q3 | -2.32 Million USD | 24.13% |
| 2016 Q1 | -3.05 Million USD | -16.92% |
| 2015 Q1 | -2.49 Million USD | -33.41% |
| 2015 Q2 | -2.49 Million USD | 0.0% |
| 2015 Q4 | -2.61 Million USD | 0.0% |
| 2015 Q3 | -2.61 Million USD | -4.74% |
| 2015 FY | -10.29 Million AUD | -67.38% |
| 2014 Q2 | -1.69 Million USD | 0.0% |
| 2014 FY | -6.15 Million AUD | 2.5% |
| 2014 Q4 | -1.87 Million USD | 0.0% |
| 2014 Q3 | -1.87 Million USD | -10.72% |
| 2014 Q1 | -1.69 Million USD | 1.55% |
| 2013 Q1 | -2.31 Million USD | -16.06% |
| 2013 FY | -6.3 Million AUD | 15.91% |
| 2013 Q4 | -1.71 Million USD | 0.0% |
| 2013 Q3 | -1.71 Million USD | 25.9% |
| 2013 Q2 | -2.31 Million USD | 0.0% |
| 2012 Q3 | -1.99 Million USD | -4.75% |
| 2012 Q1 | -1.9 Million USD | 0.0% |
| 2012 Q4 | -1.99 Million USD | 0.0% |
| 2012 Q2 | -1.9 Million USD | 0.0% |
| 2012 FY | -7.5 Million AUD | -28.74% |
| 2011 FY | -5.82 Million AUD | -33.06% |
| 2010 FY | -4.37 Million AUD | -68.78% |
| 2009 FY | -2.59 Million AUD | 36.09% |
| 2008 FY | -4.06 Million AUD | 7.04% |
| 2007 FY | -4.36 Million AUD | 3.86% |
| 2006 FY | -4.54 Million AUD | 50.58% |
| 2005 FY | -9.19 Million AUD | 0.0% |
| 2003 FY | -4.97 Million AUD | -207.56% |
| 2002 FY | -1.61 Million AUD | -25.28% |
| 2001 FY | -1.29 Million AUD | -359.04% |
| 2000 FY | 498.37 Thousand AUD | 311.44% |
| 1999 FY | -235.7 Thousand AUD | -115.65% |
| 1998 FY | 1.5 Million AUD | 1650.39% |
| 1997 FY | -97.15 Thousand AUD | 30.01% |
| 1996 FY | -138.81 Thousand AUD | -9.69% |
| 1995 FY | -126.54 Thousand AUD | 54.56% |
| 1994 FY | -278.47 Thousand AUD | -33.93% |
| 1993 FY | -207.92 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 1.649% |
| Adherium Limited | -11.98 Million AUD | -129.489% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -181.016% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -530.635% |
| Anteris Technologies Ltd | -66.63 Million AUD | 58.721% |
| Control Bionics Limited | -5.92 Million AUD | -363.885% |
| CardieX Limited | -4.63 Million AUD | -493.584% |
| Compumedics Limited | -269 Thousand AUD | -10124.907% |
| Cochlear Limited | 521.5 Million AUD | 105.274% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -471.359% |
| Cyclopharm Limited | -9.22 Million AUD | -198.168% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -1603.719% |
| Nova Eye Medical Limited | -3.79 Million AUD | -624.388% |
| HeraMED Limited | -6.42 Million AUD | -327.894% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | -56.498% |
| ImpediMed Limited | -19.03 Million AUD | -44.489% |
| InhaleRx Limited | -1.38 Million AUD | -1883.791% |
| LBT Innovations Limited | -4.74 Million AUD | -480.274% |
| Micro-X Limited | -13.02 Million AUD | -111.138% |
| Neurotech International Limited | -5.58 Million AUD | -392.498% |
| OncoSil Medical Limited | -11.98 Million AUD | -129.51% |
| PolyNovo Limited | 1.16 Million AUD | 2465.004% |
| Respiri Limited | -7 Million AUD | -292.917% |
| SomnoMed Limited | -3.84 Million AUD | -616.035% |
| Universal Biosensors, Inc. | -16.68 Million AUD | -64.895% |
| Uscom Limited | -2.4 Million AUD | -1043.969% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -369.839% |